IRadimed Corporation (IRMD) Company Profile - Business Overview, Management Team & Corporate Information - Stocknear

IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
70.27
1.72 (2.51%)
At close: Sep 26, 2025, 3:59 PM
70.27
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Company Description

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.

It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system.

The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

It serves hospitals, acute care facilities, and outpatient imaging centers.

The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors.

IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

IRadimed Corporation
IRadimed Corporation logo
Country United States
IPO Date Jul 16, 2014
Industry Medical - Devices
Sector Healthcare
Employees 160
CEO Roger E. Susi

Contact Details

Address:
1025 Willa Springs Drive
Winter Springs, Florida
United States
Website https://www.iradimed.com

Stock Details

Ticker Symbol IRMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001325618
CUSIP Number 46266A109
ISIN Number US46266A1097
Employer ID 73-1408526
SIC Code 3841

Key Executives

Name Position
Roger E. Susi Founder, Chairman, Chief Executive Officer & President
John F. Glenn Chief Financial Officer & Corporate Secretary
Chris Williamson Executive Vice President of Continuous Improvement & Information Technology
Jeff Chiprin Chief Commercial Officer
Lynn Neuhardt Vice President of Research & Development
Matt Garner Controller
Randy Waddell Vice President of Worldwide Sales & Marketing

Latest SEC Filings

Date Type Title
Sep 25, 2025 4 Filing
Sep 24, 2025 4 Filing
Sep 18, 2025 4 Filing
Sep 10, 2025 3 Filing
Sep 03, 2025 10-K/A [Amend] Annual Report
Sep 02, 2025 8-K Current Report
Aug 06, 2025 4 Filing
Aug 01, 2025 10-Q Quarterly Report
Aug 01, 2025 8-K Current Report
Jun 23, 2025 4 Filing